Company Profile

Profile last edited on: 12/21/22      CAGE: 0LTK5      UEI: CYKSLELUDGD9

Business Identifier: Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2441 South 3850 West Suite A
Salt Lake City, UT 84120
   (801) 975-1191
Location: Multiple
Congr. District: 02
County: Salt Lake

Public Profile

In May 2005, IOMED Inc was acquired by ReAble Therapeutics. Iomed products were designed to enable delivery of water-soluble ionic drugs through a patient's skin, via low levels of electricity. Advantages cited by IOMED included less-frequent and more programmable dosing, as well as potential patient self-administration. Physical therapists arereported as having used the system on more than 11 million patients to treat such conditions as tendinitis and carpal tunnel syndrome. The FDA approved the delivery system for a local dermal anesthetic and an anti-inflammatory steroid. IOMED got a boost when its dermal anesthetic Numby Stuff was used in an episode of the TV series ER. Elan International Services owns about 30% of IOMED.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1989 1 NASA $49,897
Project Title: Transdermal drug delivery system for application in space flight

Key People / Management

  Robert Lollini -- President

  Jessica Barrett